Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 3/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.36 |
| ▸ | METAP2 | P50579 | 2/20 | 0.34 |
| ▸ | REN | P00797 | 2/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CTSA | P10619 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.30 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23925288 | 1.00 | ITGB3 (0.36) | ITGB3ITGA2BMETAP2RENRIPK1 | |
| SCHEMBL23949223 | 0.89 | TSHR (0.34) | METAP2RENTSHRADAMTS5 | |
| SCHEMBL23949224 | 0.89 | TSHR (0.34) | METAP2RENTSHRADAMTS5 | |
| SCHEMBL23949222 | 0.77 | SMN1; SMN2 (0.38) | METAP2RIPK1ADAMTS5 | |
| SCHEMBL23948594 | 0.70 | OPRM1 (0.37) | METAP2TSHRADAMTS5 | |
| SCHEMBL29040715 | 0.65 | CSGALNACT1 (0.33) | ITGB3ITGA2BRIPK1 | |
| SCHEMBL29040717 | 0.65 | CSGALNACT1 (0.33) | ITGB3ITGA2BRIPK1 | |
| SCHEMBL29186832 | 0.63 | CTSA (0.34) | CTSA | |
| SCHEMBL29186833 | 0.63 | CTSA (0.34) | CTSA | |
| SCHEMBL23925075 | 0.61 | TSHR (0.45) | METAP2TSHRMMP2ADAMTS5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230148598-A1 | BETA-LACTAMS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2023-05-18 | — | — | US | disclosed |
| EP-4136071-A1 | BETA-LACTAMS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2023-02-22 | — | — | EP | disclosed |
| CN-115279735-A | Beta-lactams and their use as herbicides | 巴斯夫欧洲公司 | 2022-11-01 | — | — | CN | disclosed |
| WO-2021209268-A1 | BETA-LACTAMS AND THEIR USE AS HERBICIDES | BASF SE (DE) | 2021-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230148598-A1 | BETA-LACTAMS AND THEIR USE AS HERBICIDES | POLL, HDHD5, GLRB | ITGB3 4052/4885ITGA2B 4591/4885METAP2 2887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.